Question 1

Who owns PHAR?

Accepted Answer

PHARMING GROUP NV (PHAR) is held by 7 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is CITADEL ADVISORS LLC as of Q2 2026.

Question 2

Are institutions buying or selling PHAR?

Accepted Answer

In Q2 2026, 4 institutions opened or increased positions in PHARMING GROUP NV while 3 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on PHAR?

Accepted Answer

HoldingsIntel scores PHARMING GROUP NV across four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) — with 1 of the 4 carrying data for PHAR. In Q2 2026, the institutional leg showed net inflows: 4 buying versus 3 selling.

Question 4

How many hedge funds hold PHAR?

Accepted Answer

7 institutional investors report holding PHARMING GROUP NV (PHAR) as of Q2 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into PHAR?

Accepted Answer

As of Q2 2026, tracked institutions in PHARMING GROUP NV show 4 buyers versus 3 sellers — net inflows.

	Action
CITADEL ADVISORS LLC	Increased	11,972(+17.5%)	$162,340	0.0%	-41.31%	18
MORGAN STANLEY	Increased	11,500(+0.1%)	$159,735	0.0%	—	15
BNP PARIBAS FINANCIAL MARKETS	Decreased	300(-25.0%)	$4,167	0.0%	-32.23%	0
Optiver Holding B.V.	New	305	$4,136	0.0%	-30.81%	22
NewEdge Advisors, LLC	Decreased	187(-91.3%)	$2,596	0.0%	-42.20%	0
UBS Group AG	New	39	$542	0.0%	-30.81%	17
OSAIC HOLDINGS, INC.	Decreased	16(-87.5%)	$222	0.0%	-37.60%	0

PHARMING GROUP NV

Smart Money Verdict

Who's Trading

Continue exploring

Other Healthcare stocks held by institutions

PHARMING GROUP NV

Smart Money Verdict

Who's Trading

Top Holders

Continue exploring

Other Healthcare stocks held by institutions